Press Releases September 8, 2026 01:55 PM

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference

OPKO Health announces leadership participation in Wells Fargo’s 21st Annual Healthcare Conference

By Sofia Navarro
Share
Twitter Reddit Facebook LinkedIn
OPK

OPKO Health, a biopharmaceutical and diagnostics company, announced that its President and Vice Chairman Dr. Elias A. Zerhouni and Senior VP and CFO Adam Logal will present at the Wells Fargo 21st Annual Healthcare Conference, including a scheduled fireside chat. The event provides an opportunity to share updates and insights with investors and the healthcare community.

OPKO Health to Participate in the Wells Fargo 21st Annual Healthcare Conference
OPK
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • OPKO Health executives to participate in a major healthcare investor conference, enhancing company visibility.
  • The conference presentation includes a fireside chat accessible via webcast, facilitating investor engagement.
  • OPKO operates in biopharmaceutical and diagnostics sectors targeting serious diseases and global markets.

MIAMI, Sept. 08, 2026 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK), a fully-integrated healthcare company focused on delivering next-generation solutions for serious diseases across established global markets, today announced that Elias A. Zerhouni, M.D., President and Vice Chairman, and Adam Logal, Senior Vice President and Chief Financial Officer, will participate in the Wells Fargo 21st Annual Healthcare Conference at the Encore Boston Harbor, including a fireside chat on Thursday, September 10, 2026, at 9:30 a.m. ET.

A webcast and replay of the fireside chat can be accessed from the OPKO IR website.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development and commercialization expertise, and novel and proprietary technologies. For more information, please visit www.opko.com.

Contacts:
Alliance Advisors IR
Vivian Cervantes, 973-873-7724
[email protected]


Risks

  • The announcement does not disclose any new product or financial data, so impact depends on future communications at the event.
  • Healthcare and biopharmaceutical sectors face regulatory and market competition risks influencing company outlook.
  • Market reaction depends on content delivered during the conference; uncertainty remains until then.

More from Press Releases

ARMOUR Residential REIT, Inc. Announces Q3 Results And September 30, 2026 Financial Position Oct 21, 2026 Eagle Bancorp, Inc. Announces Third Quarter 2026 Results Oct 21, 2026 iPower Opens New AI Era with Five-Year Services LOI Targeting $21.90 Million in Potential Annualized Services Oct 15, 2026 Carpenter Technology Corporation Announces General Counsel Succession Oct 14, 2026 SNDL to Report Third Quarter 2026 Financial Results on October 27, 2026 Oct 14, 2026